SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-015734
Filing Date
2020-11-05
Accepted
2020-11-05 16:08:55
Documents
87
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20200930.htm   iXBRL 10-Q 1943962
2 EX-31.1 lnth10q-093020ex311.htm EX-31.1 11780
3 EX-31.2 lnth10q-093020ex312.htm EX-31.2 11699
4 EX-32.1 lnth10q-093020ex321.htm EX-32.1 9903
  Complete submission text file 0001628280-20-015734.txt   8171414

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20200930.xsd EX-101.SCH 50335
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20200930_cal.xml EX-101.CAL 108448
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20200930_def.xml EX-101.DEF 227061
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20200930_lab.xml EX-101.LAB 605146
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20200930_pre.xml EX-101.PRE 399067
10 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20200930_htm.xml XML 1514160
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 201290493
SIC: 2835 In Vitro & In Vivo Diagnostic Substances